At the bottom of this write up, it notes that:

Ray disclosed relevant relationships with Amgen, Sanofi, Regeneron, Esperion, Medicines Company, Boehringer Ingelheim, Novo Nordisk, Kowa, Resverlogix, Dr Reddys, Cipla, Algorithm, Zuelling Pharma, Silence Therapeutics, Cerenis, Lilly, Astra Zeneca, Bayer, Akcea, MSD, and Novartis.

Is this like a short list of companies which may be interested in buying RVX...with Pfizer thrown in for good measure (the Zenith connection)?

Iconoclast